+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Drug-Eluting Stents Market

  • ID: 5187568
  • Report
  • November 2020
  • Region: Global
  • 127 pages
  • BCC Research

FEATURED COMPANIES

  • Abbott
  • Alvimedica
  • B. Braun Melsungen Ag
  • Biosensors International
  • Biotronik Se & Co. Kg
  • Boston Scientific Corp.
  • MORE

Report Scope:

This report examines the current and projected market potential of drug-eluting stents. It offers a detailed analysis of the regulatory scenario, competitive environment, pipeline, technological advancement, drivers, restraints and market growth trends. The report also includes market projections through 2024 and the market rank for key market players. The report details the market share of drug-eluting stents based on types of products, applications and end-user.

By product type, the market is segmented into polymer-based drug-eluting stents and polymer-free drug-eluting stents. By application, the market is segmented into coronary artery disease (CAD) and peripheral artery disease (PAD). By end-user, the market is segmented into hospitals, ambulatory surgical centers and specialty centers and clinics.

By geography, the market is segmented into North America, Europe, Asia-Pacific, Latin America and the Middle East and Africa. Detailed analyses of major countries such as the U.S., Canada, Germany, the U.K., France, Spain, Italy, Japan, China and India are covered in regional segments. For market estimates, data is provided for 2018 as the base year, 2019 and forecast through year-end 2024. Estimated values used are based on drug-eluting stent manufacturers’ total revenues. Projected and forecasted revenue values are in constant U.S. dollars that have not been adjusted for inflation.

The Report Includes:

  • 20 data tables and 18 additional tables
  • An overview of the global market for drug-eluting stents within the medical devices industry
  • Estimation of the market size and analyses of market trends, with data from 2018 and 2019, and projections of compound annual growth rates (CAGRs) through 2024
  • Market share analysis of the drug-eluting stents based on product, application, end-use, and region
  • Identification of segments with high growth potential and analysis of future applications of each of the segments
  • Assessment of market dynamics for drug-eluting stents with market drivers and restraints explained, medical device regulations, market background and pipeline analysis of the stents
  • Coverage of prevalence and epidemiology of cardiovascular disease and description of coronary artery disease (CAD) and peripheral artery disease (PAD)
  • Market share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships, and other key market strategies
  • Company profiles of the leading market players, including Abbott, B. Braun Melsungen AG, Biotronik SE & Co. KG, Boston Scientific Corp., Medtronic Plc and Cook Medical Inc.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott
  • Alvimedica
  • B. Braun Melsungen Ag
  • Biosensors International
  • Biotronik Se & Co. Kg
  • Boston Scientific Corp.
  • MORE
Chapter 1 Introduction
  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Scope of Report
  • Information Sources
  • Methodology
  • Geographic Breakdown
  • Analyst's Credentials
  • Custom Research
  • Related Research Reports
Chapter 2 Summary and Highlights
  • Market Highlights: Drug-Eluting Stents
Chapter 3 Medical Device Regulations
  • Medical Device Definition and Classification
  • Regulations in the U.S.
  • Code of Federal Regulations
  • Regulations in Europe
  • Regulations in Japan
Chapter 4 Drug-Eluting Stents: Pipeline Analysis
  • Overview
Chapter 5 Drug-Eluting Stents: Market Background
  • Introduction
  • Market Evolution
  • Coating and Polymers
  • Drugs Used in DESs
  • Cardiovascular Diseases (CVDs)
  • Common Types of CVD
  • Symptoms of CVD
  • Risk Factors: CVD
  • Treatment for CVD
Chapter 6 Drug-Eluting Stents: Market Dynamics
  • Market Dynamics
  • Market Drivers
  • Market Restraints
Chapter 7 Impact of COVID-19 Pandemic
  • Introduction
  • Outbreak
  • Symptoms of COVID-19
  • Progression of COVID-19
  • Incubation Period
  • Epidemiology
  • Global Confirmed COVID-19 Cases and Deaths
  • Collaboration Between Organizations and Governments
  • Spread of Disease
  • Current Status and Impact on MedTech
  • Elective and Noncritical Procedures
  • Shift in Manufacturing
  • Regulatory Delays, Clinical Trials and Product Launches
  • Supply Chain Disruptions
  • Medical Tourism
Chapter 8 Market Breakdown, by Product
  • Global Market for Drug-Eluting Stents, by Product
  • Polymer-Based Drug-Eluting Stents
  • Market Size and Forecast
  • Market Analysis
  • Polymer-Free Drug-Eluting Stents
  • Market Size and Forecast
  • Market Analysis
Chapter 9 Market Breakdown, by Application
  • Global Market for Drug-Eluting Stents, by Application
  • Coronary Artery Disease (CAD)
  • Market Size and Forecast
  • Market Analysis
  • Peripheral Artery Disease (PAD)
  • Market Size and Forecast
  • Market Analysis
Chapter 10 Market Breakdown, by End User
  • Global Market for Drug-Eluting Stents, by End User
  • Hospitals
  • Market Size and Forecast
  • Market Analysis
  • Ambulatory Surgical Centers
  • Market Size and Forecast
  • Market Analysis
  • Specialty Centers and Clinics
  • Market Size and Forecast
  • Market Analysis
Chapter 11 Market Breakdown, by Region
  • Global Market for Drug-Eluting Stents, by Region
  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • India
  • Rest of Asia-Pacific
  • Latin America
  • Middle East and Africa
Chapter 12 Competitive Landscape
  • Global Company Share Analysis
  • Mergers and Acquisitions
  • Agreements, Collaborations, Product Launches and Partnerships
Chapter 13 Company Profiles
  • Abbott
  • Alvimedica
  • B. Braun Melsungen Ag
  • Biosensors International
  • Biotronik Se & Co. Kg
  • Boston Scientific Corp.
  • Cook Medical Inc.
  • Lepu Medical Technology (Beijing) Co., Ltd.
  • Medtronic Plc
  • Terumo Corp.
Chapter 14 Appendix: List of Acronyms

List of Tables
Summary Table A: Global Market for Drug-Eluting Stents, by Product, Through 2024
Summary Table C: Global Market for Drug-Eluting Stents, by End User, Through 2024
Summary Table B: Global Market for Drug-Eluting Stents, by Application, Through 2024
Table 1: Class I and II Exempt Devices
Table 2: Selected Clinical Trial Studies: Drug-Eluting Stents
Table 3: Selected Coronary Stents
Table 4: Drugs Commonly Used in DES
Table 5: CVD Risk Factors
Table 6: Coronary Angioplasty Procedures, by Country, 2018
Table 7: Distribution of COVID-19 Symptoms
Table 8: COVID-19: Confirmed Cases and Deaths, by Country, as of Aug. 3, 2020
Table 9: Global Market for Drug-Eluting Stents, by Product Segment, Through 2024
Table 10: Common Polymers Used in DES
Table 11: Coating Methods to Develop Polymer‐Free Drug‐Eluting Stents
Table 12: Global Market for Drug-Eluting Stents, by Application, Through 2024
Table 13: Global Market for Drug-Eluting Stents, by End User, Through 2024
Table 14: Global Market for Drug-Eluting Stents, by Region, Through 2024
Table 15: North American Market for Drug-Eluting Stents, by Country, Through 2024
Table 16: Estimated Number of U.S. Stent Procedures, by Type of Procedure, 2014
Table 17: European Market for Drug-Eluting Stents, by Country, Through 2024
Table 18: Asia-Pacific Market for Drug-Eluting Stents, by Country, Through 2024
Table 19: Latin American Market for Drug-Eluting Stents, by Product, Through 2024
Table 20: Latin American Market for Drug-Eluting Stents, by Application, Through 2024
Table 21: Latin American Market for Drug-Eluting Stents, by End User, Through 2024
Table 22: Leading Causes of Death and Percentage Change in Argentina, 2007-2017
Table 23: Middle Eastern and African Market for Drug-Eluting Stents, by Product, Through 2024
Table 24: Middle Eastern and African Market for Drug-Eluting Stents, by Application, Through 2024
Table 25: Middle Eastern and African Market for Drug-Eluting Stent, by End User, Through 2024
Table 26: Global Market Shares of Drug-Eluting Stents, by Company, 2019
Table 27: Abbott: Drug-Eluting Stents, Product Portfolio
Table 28: Alvimedica: Drug-Eluting Stents, Product Portfolio
Table 29: B. Braun Melsungen AG: Drug-Eluting Stents, Product Portfolio
Table 30: Biosensors International: Drug-Eluting Stents, Product Portfolio
Table 31: Biotronik SE & Co. KG: Drug-Eluting Stents, Product Portfolio
Table 32: Boston Scientific Corp.: Drug-Eluting Stents, Product Portfolio
Table 33: Cook Medical Inc.: Drug-Eluting Stents, Product Portfolio
Table 34: Lepu Medical Technology (Beijing) Co., Ltd.: Drug-Eluting Stents, Product Portfolio
Table 35: Medtronic Plc: Drug-Eluting Stents, Product Portfolio
Table 36: Terumo Corp.: Drug-Eluting Stents, Product Portfolio
Table 37: Acronyms Used in the Drug-Eluting Stents Industry

List of Figures
Summary Figure C: Global Market for Drug-Eluting Stents, by Application, 2018-2024
Summary Figure B: Global Market Shares of Drug-Eluting Stents, by Product, 2019
Summary Figure A: Global Market for Drug-Eluting Stents, by Product, 2018-2024
Summary Figure D: Global Market Shares of Drug-Eluting Stents, by Application, 2019
Summary Figure E: Global Market for Drug-Eluting Stents, by End User, 2018-2024
Summary Figure F: Global Market Shares of Drug-Eluting Stents, by End User, 2019
Figure 1: Marketing a Medical Device in the U.S.
Figure 2: Historical Milestones: Coronary Artery Stenting
Figure 3: Global Disease Burden, 2017
Figure 4: Adults with Cardiovascular Conditions, by Country, 2019
Figure 5: Top 10 Global Causes of Deaths, 2016
Figure 6: Global Geriatric Population (Aged 65+ Years), 2014-2022
Figure 7: Surgical Operations Performed Globally, 2004 and 2012
Figure 8: Global Market Shares of Drug-Eluting Stents, by Product Segment, 2019
Figure 9: Global Market for Polymer-Based Drug-Eluting Stents, 2018-2024
Figure 10: Global Market for Polymer-Based Drug-Eluting Stents, by Region, 2018-2024
Figure 11: Global Market for Polymer-Free Drug-Eluting Stents, 2018-2024
Figure 12: Global Market for Polymer-Free Drug-Eluting Stents, by Region, 2018-2024
Figure 13: Global Market Shares of Drug-Eluting Stents, by Application, 2019
Figure 14: Global Market for Coronary Artery Disease, 2018-2024
Figure 15: Global Market for Peripheral Artery Disease, 2018-2024
Figure 16: Global Market Shares of Drug-Eluting Stents, by End User, 2019
Figure 17: Global Market for Drug-Eluting Stents in Hospital End Use, 2018-2024
Figure 18: Global Market for Drug-Eluting Stents in Ambulatory Surgical Center End Use, 2018-2024
Figure 19: Global Market for Drug-Eluting Stents in Specialty Center and Clinic End Use, 2018-2024
Figure 20: Global Market Shares of Drug-Eluting Stents, by Region, 2019
Figure 21: North American Market Shares of Drug-Eluting Stents, by Country, 2019
Figure 22: U.S. Market for Drug-Eluting Stents, 2018-2024
Figure 23: U.S. Population Aged 65+, Projection and Trends, 2010-2050
Figure 24: Distribution of Deaths in the U.S. from CVD, by Disease Sub-Segment, 2016
Figure 25: Canadian Market for Drug-Eluting Stents, 2018-2024
Figure 26: European Market Shares of Drug-Eluting Stents, by Country, 2019
Figure 27: German Market for Drug-Eluting Stents, 2018-2024
Figure 28: U.K. Market for Drug-Eluting Stents, 2018-2024
Figure 29: French Market for Drug-Eluting Stents, 2018-2024
Figure 30: Italian Market for Drug-Eluting Stents, 2018-2024
Figure 31: Spanish Market for Drug-Eluting Stents, 2018-2024
Figure 32: Rest of European Market for Drug-Eluting Stents, 2018-2024
Figure 33: Asia-Pacific Market Shares of Drug-Eluting Stents, by Country, 2019
Figure 34: Japanese Market for Drug-Eluting Stents, 2018-2024
Figure 35: Chinese Market for Drug-Eluting Stents, 2018-2024
Figure 36: Shares of Major Causes of Death in Rural China, 2016
Figure 37: Shares of Major Causes of Death in Urban China, 2016
Figure 38: Indian Market for Drug-Eluting Stents, 2018-2024
Figure 39: Rest of Asia-Pacific Market for Drug-Eluting Stents, 2018-2024
Figure 40: Latin American Market for Drug-Eluting Stents, 2018-2024
Figure 41: Latin American Market Shares of Drug-Eluting Stents, by Product, 2019
Figure 42: Middle Eastern and African Market for Drug-Eluting Stents, 2018-2024
Figure 43: Middle Eastern and African Market Shares of Drug-Eluting Stents, by Product, 2019
Figure 44: Abbott: Annual Revenue, 2017-2019
Figure 45: Abbott: Revenue Share, by Country, 2019
Figure 46: Abbott: Revenue Share, by Product Category, 2019
Figure 47: B. Braun Melsungen AG: Annual Revenue, 2017-2019
Figure 48: B. Braun Melsungen AG: Revenue Share, by Business Division, 2019
Figure 49: B. Braun Melsungen AG: Revenue Share, by Country/Region, 2019
Figure 50: Boston Scientific Corp.: Annual Revenue, 2017-2019
Figure 51: Boston Scientific Corp.: Revenue Share, by Product Category, 2019
Figure 52: Boston Scientific Corp.: R&D Expenditures, 2017-2019
Figure 53: Lepu Medical Technology (Beijing) Co., Ltd.: Annual Revenue, 2017-2019
Figure 54: Medtronic Plc: Annual Revenue, 2017-2019
Figure 55: Medtronic Plc: Revenue Share, by Country/Region, 2019
Figure 56: Medtronic Plc: Revenue Share, by Product Category, 2019
Figure 57: Terumo Corp.: Annual Revenue, 2017-2019
Figure 58: Terumo Corp.: Revenue Share, by Product Category, 2019
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott
  • Alvimedica
  • B. Braun Melsungen Ag
  • Biosensors International
  • Biotronik Se & Co. Kg
  • Boston Scientific Corp.
  • MORE

The global market growth is attributed to the growing prevalence of cardiovascular diseases, a rise in the world’s geriatric population, and growing demand for minimally invasive procedures.

There has been remarkable growth in the development of coronary stents to avoid restenosis and thrombosis. Improvements include progress in the design and conformation of metallic or resorbable structures, with an adequate balance between trackability and radial force. Also noted is the development of antiproliferative drugs and polymers to control release and allow adequate endothelialization and optimal duration of the antiplatelet regimen. These developments led to growth in the drug-eluting stent market over the forecast period. 

Drug-eluting stents are coated with a drug and polymer, designed to allow for a controlled and consistent release of the drug from the stent surface into the artery walls. Both the amount of drug and release rate has been determined so that healing can occur while allowing the processes leading to restenosis to be minimized, reducing the need for additional treatment in the stented area.

Rising incidence of CVD, heart failure, and coronary heart disease cases come with a growing prevalence of obesity, diabetes, and high blood pressure, globally. These phenomena are anticipated to fuel drug-eluting stents market growth over the forecast period. 

Note: Product cover images may vary from those shown
  • Abbott
  • Alvimedica
  • B. Braun Melsungen Ag
  • Biosensors International
  • Biotronik Se & Co. Kg
  • Boston Scientific Corp.
  • Cook Medical Inc.
  • Lepu Medical Technology (Beijing) Co., Ltd.
  • Medtronic Plc
  • Terumo Corp.
Note: Product cover images may vary from those shown
Adroll
adroll